This purified, recombinant, human biotinylated Fab recognizes L3MBTL4 in human samples.

Recombinant antibody characteristics include:
• Validation in immunoprecipitation
• Superior lot-to-lot consistency
• Extremely high specificity and sensitivity
• Recombinant human biotinylated Fab
• Specific for L3MBTL4

The L3MBTL4 gene is one of four human orthologs of Drosophila lethal malignant brain tumor. The L3MBTL4 protein contains three "malignant brain tumor" (MBT) domains. This domain of about 100 amino acid residues is conserved in protostomians and deuterostomians and often exists as repeats. The MBT domain binds methylated histone residues.br>
Exceptional Consistency Saves You Time and Money
Recombinant antibodies are produced by transfection of mammalian cells with heavy and light chain antibody cDNAs. This provides you with the highest consistency between lots, eliminating the need to revalidate your assays for each lot.

High Specificity Means More Reliable Data
The recombinant technology employed in manufacture of the antibody assures the greatest degree of reliability. Staining of nonspecific proteins is virtually eliminated, while very high sensitivity is achieved. Life Technologies has validated this antibody in immunoprecipitation.

High Sensitivity Lets You Detect Low Levels of Target Protein
Recombinant antibodies demonstrate much higher sensitivity than ordinary antibodies. Proteins expressed at low levels can be detected with high specificity allowing you to use less of your precious samples than with ordinary antibodies.

Recombinant Mouse IgG-Use Like Any Other IgG Antibody
As with traditional IgG antibodies, gel electrophoresis of recombinant antibodies produces a 150 kDa band under non-reducing conditions and 50 kDa and 25 kDa bands under reducing conditions.

Related Links:
Learn more about the superior performance of ABfinity™recombinant monoclonal antibodies.
See Life Technologies' full line of ABfinity™recombinant monoclonal antibodies.